352
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Monitoring and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis: Brazilian Evidence-based Practice Guidelines

, MD, , MD, , MD, , MD, , MDORCID Icon, , MD, , MD, , MD, , MD, , MD, & , MD show all
Pages 1384-1398 | Received 21 Oct 2020, Accepted 11 Jan 2021, Published online: 07 Apr 2021

References

  • Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Best Pract Res Clin Rheumatol. 2017;31(4):517–534. doi:10.1016/j.berh.2018.01.002.
  • Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112–117. doi:10.1016/j.jbspin.2013.09.003.
  • Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180–191. doi:10.3109/09273948.2013.791701.
  • Jari M, Shiari R, Salehpour O, Rahmani K. Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15(1):41. doi:10.1186/s13023-020-1324-x.
  • Heiligenhaus A, Minden K, Tappeiner C, et al. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2019;49:43–55. doi:10.1016/j.semarthrit.2018.11.004.
  • de Moraes AJPVA, Bica BERG, Len C, et al. Projeto Diretrizes; Artrite Idiopática Juvenil: diagnóstico. In: Reumatologia SBdPeSBd. ed. Sao Paulo, Brazil: AMB; 2012:1–16.
  • Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926. doi:10.1136/bmj.39489.470347.AD.
  • Angeles-Han ST, Ringold S, Beukelman T, et al. American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken). 2019;2019(71):703–716. doi:10.1002/acr.23871.
  • Nordal E, Rypdal V, Christoffersen T, et al. Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatr Rheumatol Online J. 2017;15(1):66. doi:10.1186/s12969-017-0195-8.
  • Consolaro A, Giancane G, Alongi A, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–263. doi:10.1016/S2352-4642(19)30027-6.
  • Fernandez DGNH, Nascimento C, Muccioli C, Belfort Jr RM. Uveitis in São Paulo, Brazil: 1053 New Patients in 15 Months. Ocul Immunol Inflamm. 2017;25:382–387. doi:10.3109/09273948.2015.1132741.
  • Haasnoot AJWKJ, Boer JH. Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice. Expert Rev Clin Immunol. 2019;15:657–666. doi:10.1080/1744666X.2019.1593139.
  • Tappeiner C, Klotsche J, Sengler C, et al. Risk Factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study. Arthritis Rheumatol. 2018;70:1685–1694. doi:10.1002/art.40544.
  • Pelegrín L, Casaroli-Marano R, Jordi Antón J, et al. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2014;22:208–212. doi:10.3109/09273948.2013.841495.
  • Haasnoot AJW, Schilham MW, Kamphuis S, et al. Identification of an amino acid motif in HLA-DRβ1 that distinguishes uveitis in patients with juvenile idiopathic arthritis. Arthritis Rheumatol. 2018;70:1155–1165. doi:10.1002/art.40484.
  • Lambert SR, Lyons CJ. Taylor and Hoyt’s Pediatric Ophthalmology and Strabismus. 5th. Amsterdam: Elsevier; 2016.
  • Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K, German Uveitis in Childhood Study G. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46(6):1015–1019. doi:10.1093/rheumatology/kem053.
  • Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62(6):1824–1828. doi:10.1002/art.27416.
  • Kotaniemi K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis A prospective study. Ophthalmology. 2001;108(11):2071–2075. doi:10.1016/S0161-6420(01)00773-4.
  • Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–1984. doi:10.1002/art.22709.
  • Hawkins MJ, Dick AD, Lee RJ, et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol. 2016;61:197–210. doi:10.1016/j.survophthal.2015.10.005.
  • Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol. 1997;24:1826–1829.
  • Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007;56(2):647–657. doi:10.1002/art.22381.
  • Roberto AM, Terreri MT, Len C, Muccioli C, Hilario MO. [Uveitis in juvenile idiopathic arthritis]. J Pediatr (Rio J). 2002;78:62–66. doi:10.2223/JPED.667.
  • Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019;58:975–986. doi:10.1093/rheumatol-ogy/key406.
  • Angeles-Han ST, Yeh S, Vogler LB. Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis. Int J Clin Rheumtol. 2013;8(1): doi:10.2217/ijr.12.83.
  • Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757–762. doi:10.1016/S0002-9394(03)00225-3.
  • Edelsten C1, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–56.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Chylack LT Jr. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum. 1977;20:217–223.
  • Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104(2):236–244. doi:10.1016/S0161-6420(97)30329-7.
  • Kanski JJ. Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol. 1977;95:1794–1797. doi:10.1001/archopht.1977.04450100096010.
  • Sabri K, Saurenmann RK, Silverman ED, Levin AV. Course, complications, and outcome of juvenile arthritis-related uveitis. J Aapos. 2008;12:539–545. doi:10.1016/j.jaapos.2008.03.007.
  • Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):281–290. doi:10.1007/s00417-005-0087-3.
  • Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol. 2008;35:703–706.
  • Davies K, Cleary G, Foster H, et al. BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49:1406–1408. doi:10.1093/rheumatology/kep460.
  • Bou R, Adan A, Borrás F, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35:777–785. doi:10.1007/s00296-015-3231-3.
  • Foeldvari I, Klotsche J, Simonini G, et al. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatr Rheumatol Online J. 2019;17:66.
  • The Royal College of Ophthalmologists. British Society of Paediatric and Adolescent Rheumatology Guidelines for Screening for Uveitis in Juvenile Idiopathic Arthritis. London; 2006.
  • Rhee DJ, Pyfer MF. The Wills eye manual: office and emergency room diagnosis and treatment of eye disease Wills eye hospital. In: Anterior Uveitis (Iritis/iridocyclitis). Chapter 12; 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999.
  • Heiligenhaus A, Michels H, Schumacher C, et al. Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int. 2012;32(5):1121–1133. doi:10.1007/s00296-011-2126-1.
  • Gaudio PA. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm. 2004;12(3):169–192. doi:10.1080/092739490500192.
  • Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990;34(4):253–267. doi:10.1016/0039-6257(90)90026-R.
  • Roesel M, Gutfleisch M, Heinz C, Heimes B, Zurek-Imhoff B, Heiligenhaus A. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Ophthalmic Res. 2009;42(2):81–86. doi:10.1159/000220600.
  • Roesel M, Gutfleisch M, Heinz C, Heimes B, Zurek-Imhoff B, Heiligenhaus A. Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis. Eye (Lond). 2009;23(4):910–914. doi:10.1038/eye.2008.114.
  • Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108(4):765–772. doi:10.1016/S0161-6420(00)00658-8.
  • Heiligenhaus A, Bertram B, Heinz C, et al. Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: date: 02/07/2014. Ophthalmologe. 2014;111:740–748. doi:10.1007/s00347-014-3130-0.
  • Pleyer U, Klamann M, Laurent TJ, et al. Fast and Successful Management of Intraocular Inflammation with a Single Intravitreal Dexamethasone Implant. Ophthalmologica. 2014. doi:10.1159/000368987.
  • Sallam A, Comer RM, Chang JH, et al. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children. Arch Ophthalmol. 2008;126(2):200–205. doi:10.1001/archophthalmol.2007.59.
  • Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT. Current Evidence of Anti-Tumor Necrosis Factor α Treatment Efficacy in Childhood Chronic Uveitis: a Systematic Review and Meta-Analysis Approach of Individual Drugs. Arthritis Care Res (Hoboken). 2014;66(7):1073–1084. doi:10.1002/acr.22214.
  • US Food and Drug Administration (FDA). Abatacept. Reference ID: 3428402, 2013.
  • US Food and Drug Administration (FDA). Adalimumab. Reference ID: 4359269, 2018.
  • US Food and Drug Administration (FDA). Cyclosporin. Reference ID: 3303454
  • US Food and Drug Administration (FDA). Infliximab. Reference ID: 4608934. Maryland; 2020.
  • US Food and Drug Administration (FDA). Mycophenolate mofetil. Reference ID: 4310726 2018.
  • US Food and Drug Administration (FDA). Methotrexate. Reference ID: 4526395 2019.
  • US Food and Drug Administration (FDA). Tocilizumab. Reference ID: 3393637. 2013.
  • Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104(6):847–851. doi:10.1001/archopht.1986.01050180081035.
  • Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107–1117. doi:10.1136/annrheumdis-2018-213131.
  • Esmael A, Ismail YM, Elhusseiny AM, Fayed AE, Elhilali HM. Agreement profiles for rebound and applanation tonometry in normal and glaucomatous children. Eur J Ophthalmol. 2019;29(4):379–385. doi:10.1177/1120672118795060.
  • Rolim-de-moura CFNC, Esporcatte BLB. Glaucoma Na Infância. 1st ed. Sao Paulo: Cultura Medica; 2019.
  • Choi J, Hawley DP, Ashworth J, Edelsten C, Bossuyt A. An update on the modern management of paediatric uveitis. Br J Ophthalmol. 2019;103:1685–1689. doi:10.1136/bjophthalmol-2019-314212.
  • Sijssens KM, Rothova A, Berendschot TT, de Boer JH. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113:853–9 e2. doi:10.1016/j.ophtha.2006.01.043.
  • Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol. 2013;155(1):134–142. doi:10.1016/j.ajo.2012.07.008.
  • Foster CS, Havrlikova K, Baltatzis S, Christen WG, Merayo-Lloves J. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand. 2000;78(5):576–579. doi:10.1034/j.1600-0420.2000.078005576.x.
  • Frezzotti P, Mittica V, Martone G, et al. Longterm follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta Ophthalmol. 2010;88:150–155. doi:10.1111/j.1755-3768.2008.01354.x.
  • Dastiridou AIAS, Praidou A, Brazitikos P, Brozou CG, Tsironi EE. Transscleral diode laser cyclophotocoagulation for refractory glaucoma secondary to juvenile idiopathic arthritis: a short term follow-up. Int Ophthalmol. 2013;33:409–413. doi:10.1007/s10792-012-9672-8.
  • Ho CLWE. Goniosurgery for glaucoma complicating chronic childhood uveitis. Arch Ophthalmol. 2004;122(6):838–844. doi:10.1001/archopht.122.6.838.
  • Freedman SF-R-R-R, Rojas MC, Enyedi LB. Goniotomy for glaucoma secondary to chronic childhood uveitis. Am J Ophthalmol. 2002;133:617–662. doi:10.1016/S0002-9394(02)01344-2.
  • Ho CLWD. Goniosurgery for glaucoma secondary to chronic anterior uveitis: prognostic factors and surgical technique. J Glaucoma. 2004;13:445–449. doi:10.1097/01.ijg.0000141368.96950.3c.
  • Carreno EVS, Portero A, Herraras JM, Maquet JA, Calonge M. Surgical outcomes of uveitic glaucoma. J Ophthalmol Inflamm Infect. 2011;1:43–53. doi:10.1007/s12348-010-0012-8.
  • Papadaki TGZI, Pasquale LR, Christen WB, Netland PA, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62–69. doi:10.1016/j.ajo.2007.03.013.
  • Rolim de Moura CF-BS, Stout A, Labree L, Nilfours M, Varma R. Experience with the Baerveldt glaucoma implant in the management of pediatric glaucoma. Am J Ophthalmol. 2005;139:847–854. doi:10.1016/j.ajo.2004.12.028.
  • Kafkala CHA, Choi J, Topalkara A, Foster CS. Ahmed valve implantation for uncontrolled pediatric uveitic glaucoma. J Aapos. 2005;9:336–340. doi:10.1016/j.jaapos.2005.04.006.
  • Kotaniemi -KS-K-K. Occurrence and management of ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis: an observational series of 104 patients. Clin Ophthalmol. 2007;1:455–459.
  • Wang QWJ, Fortin E, Hamel P. Trabeculotomy in the Treatment of Pediatric Uveitic Glaucoma. J Glaucoma. 2016;25:744–749. doi:10.1097/IJG.0000000000000516.
  • Wiese CHA, Heinz C. Changes in Inflammatory Activity after Glaucoma Filtration Surgery in Children with Chronic Anterior Uveitis. Ocul Immunol Inflamm. 2016;24:397–401. doi:10.3109/09273948.2015.1088041.
  • Acevedo S, Quinones K, Rao V, Cervantes-Castaneda RA, Foster CS. Cataract surgery in children with juvenile idiopathic arthritis associated uveitis. Int Ophthalmol Clin. 2008;48(2):1–7. doi:10.1097/IIO.0b013e3181695b80.
  • Phatak S, Lowder C, Pavesio C. Controversies in intraocular lens implantation in pediatric uveitis. J Ophthalmic Inflamm Infect. 2016;6(1):12. doi:10.1186/s12348-016-0079-y.
  • Grajewski RSZ-IB, Roesel M, Heinz C, Heiligenhaus A. Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis. Acta Ophthalmol. 2012;90:657–662. doi:10.1111/j.1755-3768.2011.02110.x.
  • Terrada C, Julian K, Cassoux N, et al. Cataract surgery with primary intraocular lens implantation in children with uveitis: long-term outcomes. J Cataract Refract Surg. 2011;37:1977–1983. doi:10.1016/j.jcrs.2011.05.037.
  • Benezra DCE. Cataract surgery in children with chronic uveitis. Ophthalmology. 2000;107(7):1255–1260. doi:10.1016/S0161-6420(00)00160-3.
  • Akinci ACN, Uncu N, Kara N, Acaroglu G. Keratoconjunctivitis sicca in juvenile rheumatoid arthritis. Cornea. 2007;26:941–944. doi:10.1097/ICO.0b013e3180de1f34.
  • Magli AFR, Rombetto L, Alessio M. Cataract management in juvenile idiopathic arthritis: simultaneous versus secondary intraocularlens implantation. Ocul Immunol Inflamm. 2014;22:133–137. doi:10.3109/09273948.2013.834062.
  • Kotaniemi K, Penttila H. Intraocular lens implantation in patients with juvenile idiopathic arthritis associated uveitis. Ophthalmic Res. 2006;38:318–323. doi:10.1159/000096225.
  • Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100(6):809–817. doi:10.1016/S0161-6420(93)31568-X.
  • Lundvall A. Cataract extraction and intraocular lens implantation in children with uveitis. Br J Ophthalmol. 2000;84(7):791–793. doi:10.1136/bjo.84.7.791.
  • Alves C, Robazzi TC, Mendonca M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr (Rio J). 2008;84:192–202. doi:10.2223/JPED.1773.
  • Paroli MPFC, Spinucci G, Abicca I, Sapia A, Spadea L. Severe macular edema in patients with juvenile idiopathic arthritis-related uveitis. Case Rep Ophthalmol Med. 2013;2013:803989.
  • Thorne JEWF, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840–846. doi:10.1016/j.ajo.2007.01.033.
  • Tappeiner C, Mesquida M, Adán A, et al. Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2016;43:2183–2188. doi:10.3899/jrheum.160231.
  • Garweg JG. Macular Edema in Childhood Uveitis. Klin Monbl Augenheilkd. 2018;235:373–376. doi:10.1055/s-0043-123650.
  • Pichi F, Nucci P, Baynes K, Lowder CY, Srivastava SK. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis. Int Ophthalmol. 2017;37(1):221–228. doi:10.1007/s10792-016-0265-9.
  • Ministerio da Saude. Protocolo Clínico E Diretrizes Terapêuticas Da Artrite Reumatoide E Artrite Idiopática Juvenil. Brasilia: Conitec; 2020.
  • Schinzel V, Silva SGL, Terreri MT, Len CA. Prevalence of juvenile idiopathic arthritis in school children from the city of São Paulo, the largest city in Latin America. Adv Rheumatol. 2019;59:32. doi:10.1186/s42358-019-0078-4.
  • Yamashita E, Terreri MT, Hilário MO, Len CA. Prevalence of juvenile idiopathic arthritis in children aged 6 to 12 years in Embu das Artes, state of Sao Paulo, Brazil. Rev Bras Reumatol. 2013;53:542–545. doi:10.1016/j.rbr.2013.04.005.
  • Santos FPST, Carvalho MAP, Pinto JA, ea. Juvenile Idiopathic Arthritis in a Department of Rheumatology: Belo Horizonte. Minas Gerais: Rev Med Minas Gerais; 2010:20.
  • Palman JS-WS, Hyrich K, McDonagh JE. Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis. Best Practice & Research Clinical Rheumatology. 2018;32:206–222. doi:10.1016/j.berh.2018.10.004.
  • Fernandes TAPCJ, Magalhães CS. Remission status follow-up in children with juvenile idiopathic arthritis. J Pediatr. 2007;83:141–148. doi:10.1590/S0021-75572007000200008.
  • Kulas DTSL. Juvenile idiopathic arthritis. Review Curr Opin Rheumatol. 2001;13:392–398. doi:10.1097/00002281-200109000-00009.
  • Sarens IL, Casteels I, Anton J, et al. Blau Syndrome-Associated Uveitis: preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol. 2018;187:158–166. doi:10.1016/j.ajo.2017.08.017.
  • Schaller JG. Ankylosing spondylitis of childhood onset. Arthritis Rheum. 1977;20:398–401.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.